Cryoport, Inc. Files 8-K Report

Ticker: CYRX · Form: 8-K · Filed: Aug 6, 2024 · CIK: 1124524

Cryoport, Inc. 8-K Filing Summary
FieldDetail
CompanyCryoport, Inc. (CYRX)
Form Type8-K
Filed DateAug 6, 2024
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.001, $200,000,000, $160 million, $885, $1,000
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k

TL;DR

Cryoport filed an 8-K on Aug 1st, check for updates.

AI Summary

On August 1, 2024, Cryoport, Inc. filed an 8-K report to disclose other events and financial statements/exhibits. The filing does not contain specific financial figures or details about the nature of the 'other events' beyond its classification.

Why It Matters

This 8-K filing indicates that Cryoport, Inc. has made a regulatory submission to the SEC, which may contain important updates or disclosures relevant to investors.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for 'Other Events' and does not contain immediate negative or positive financial news.

Key Players & Entities

  • Cryoport, Inc. (company) — Registrant
  • August 1, 2024 (date) — Date of earliest event reported
  • Nevada (jurisdiction) — State of incorporation
  • 112 Westwood Place, Suite 350 (address) — Principal executive offices
  • Brentwood, TN 37027 (address) — Principal executive offices

FAQ

What specific 'Other Events' are being reported by Cryoport, Inc. in this 8-K filing?

The filing indicates 'Other Events' as an item information, but does not specify the nature of these events within the provided text.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on August 1, 2024.

What is Cryoport, Inc.'s state of incorporation?

Cryoport, Inc. is incorporated in Nevada.

Where are Cryoport, Inc.'s principal executive offices located?

Cryoport, Inc.'s principal executive offices are located at 112 Westwood Place, Suite 350, Brentwood, TN 37027.

What is the SEC file number for Cryoport, Inc.?

The SEC file number for Cryoport, Inc. is 001-34632.

Filing Stats: 703 words · 3 min read · ~2 pages · Grade level 11.8 · Accepted 2024-08-06 16:34:57

Key Financial Figures

  • $0.001 — e on which registered Common Stock, $0.001 par value CYRX The NASDAQ Stock Mar
  • $200,000,000 — a repurchase program to purchase up to $200,000,000 of the Company's common stock and/or co
  • $160 million — 026 Notes") to repurchase approximately $160 million aggregate principal amount of the 2026
  • $885 — the 2026 Notes at a repurchase price of $885 for each $1,000 principal amount of the
  • $1,000 — at a repurchase price of $885 for each $1,000 principal amount of the 2026 Notes repu
  • $186.2 million — Following such closings, approximately $186.2 million principal amount of the 2026 Notes will
  • $402.5 million — an initial issued principal balance of $402.5 million. A copy of the press release issued by

Filing Documents

01 Other Events

Item 8.01 Other Events. Repurchase Program On August 6, 2024, Cryoport, Inc. (the "Company") issued a press release announcing that the Company's Board of Directors had authorized a repurchase program to purchase up to $200,000,000 of the Company's common stock and/or convertible senior notes (the "2024 Repurchase Program"). The 2024 Repurchase Program became effective on August 1, 2024 and remains in effect through December 31, 2027. The size and timing of any repurchase will depend on a number of factors, including the market price of the Company's common stock, general market and economic conditions, and applicable legal requirements. Convertible Note Repurchase On August 6, 2024, the Company entered into separate, privately negotiated transactions (the "Agreements") with certain holders of its existing 0.75% Convertible Senior Notes due 2026 (the "2026 Notes") to repurchase approximately $160 million aggregate principal amount of the 2026 Notes at a repurchase price of $885 for each $1,000 principal amount of the 2026 Notes repurchased, plus accrued and unpaid interest. The repurchase of the 2026 Notes was made under the 2024 Repurchase Program. The 2026 Notes repurchases are expected to close on August 9, 2024, subject to customary closing conditions. Following such closings, approximately $186.2 million principal amount of the 2026 Notes will remain outstanding, from an initial issued principal balance of $402.5 million. A copy of the press release issued by the Company on August 6, 2024 discussing the repurchase program and the convertible note repurchase is attached as Exhibit 99.1. The information, including the exhibit attached hereto, in this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 o

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release dated August 6, 2024 issued by the Company. 104 Cover Page Interactive Data File (embedded within the inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 6, 2024 Cryoport Inc. /s/ Robert Stefanovich Robert Stefanovich Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.